154 related articles for article (PubMed ID: 31542871)
1. A case of female Fabry disease revealed by renal biopsy.
Aratani S; Yamakawa H; Suzuki S; Otsuka T; Sakai Y; Shimizu A; Tsuruoka S
CEN Case Rep; 2020 Feb; 9(1):24-29. PubMed ID: 31542871
[TBL] [Abstract][Full Text] [Related]
2. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
[TBL] [Abstract][Full Text] [Related]
3. A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
Takahashi N; Yokoi S; Kasuno K; Kogami A; Tsukimura T; Togawa T; Saito S; Ohno K; Hara M; Kurosawa H; Hirayama Y; Kurose T; Yokoyama Y; Mikami D; Kimura H; Naiki H; Sakuraba H; Iwano M
Clin Nephrol; 2015 May; 83(5):301-8. PubMed ID: 25295576
[TBL] [Abstract][Full Text] [Related]
4. A case of latent heterozygous Fabry disease in a female living kidney donor candidate.
Minami M; Mizuma E; Nakahara M; Oda Y; Yoshimine H; Tokunaga K; Mitsuke A; Yamada Y; Enokida H; Masutani K; Goto N; Ido A
CEN Case Rep; 2021 Feb; 10(1):30-34. PubMed ID: 32712909
[TBL] [Abstract][Full Text] [Related]
5. A Case of a 49-Year-Old Man with Nonclassical Fabry Disease Diagnosed by Renal Biopsy.
Fu L; Zhang P; Ye Q; Wu M; He L
Nephron; 2022; 146(1):45-48. PubMed ID: 34521087
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of Fabry disease with IgM nephropathy: A case report.
Wu H; Behera TR; Gong J; Shen Q
Medicine (Baltimore); 2019 Oct; 98(41):e17566. PubMed ID: 31593141
[TBL] [Abstract][Full Text] [Related]
7. Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid Deposits.
Svarstad E; Leh S; Skrunes R; Kampevold Larsen K; Eikrem Ø; Tøndel C
Nephron; 2018; 138(1):13-21. PubMed ID: 28848191
[TBL] [Abstract][Full Text] [Related]
8. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
9. Fabry Nephropathy: An Evidence-Based Narrative Review.
Del Pino M; Andrés A; Bernabéu AÁ; de Juan-Rivera J; Fernández E; de Dios García Díaz J; Hernández D; Luño J; Fernández IM; Paniagua J; Posada de la Paz M; Rodríguez-Pérez JC; Santamaría R; Torra R; Ambros JT; Vidau P; Torregrosa JV
Kidney Blood Press Res; 2018; 43(2):406-421. PubMed ID: 29558749
[TBL] [Abstract][Full Text] [Related]
10. Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening.
Chen Z; Yin B; Jiao J; Ye T
BMC Nephrol; 2024 Feb; 25(1):61. PubMed ID: 38383316
[TBL] [Abstract][Full Text] [Related]
11. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy.
Odani K; Okumi M; Honda K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():57-9. PubMed ID: 26971403
[TBL] [Abstract][Full Text] [Related]
13. Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys.
Cybulla M; Schaefer E; Wendt S; Ling H; Kröber SM; Hövelborn U; Schandelmaier S; Rohrbach R; Neumann HP
Am J Kidney Dis; 2005 May; 45(5):e82-9. PubMed ID: 15861341
[TBL] [Abstract][Full Text] [Related]
14. A characteristic dissection microscopy appearance of a renal biopsy of a Fabry heterozygote.
Yuen NW; Lam CW; Chow TC; Chiu MC
Nephron; 1997; 77(3):354-6. PubMed ID: 9375832
[TBL] [Abstract][Full Text] [Related]
15. Renal globotriaosylceramide deposits for Fabry disease linked to uncertain pathogenicity gene variant c.352C>T/p.Arg118Cys: A family study.
Cerón-Rodríguez M; Ramón-García G; Barajas-Colón E; Franco-Álvarez I; Salgado-Loza JL
Mol Genet Genomic Med; 2019 Nov; 7(11):e981. PubMed ID: 31566927
[TBL] [Abstract][Full Text] [Related]
16. An asymptomatic heterozygous female with fabry disease: implications for enzyme replacement therapy.
Inagaki S; Migita M; Hayakawa M; Fujita A; Yoshida J; Ishizaki M; Kotani M; Sakuraba H; Shimada T; Murakami M; Fukunaga Y
J Nippon Med Sch; 2005 Dec; 72(6):387-90. PubMed ID: 16415520
[TBL] [Abstract][Full Text] [Related]
17. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.
Najafian B; Svarstad E; Bostad L; Gubler MC; Tøndel C; Whitley C; Mauer M
Kidney Int; 2011 Mar; 79(6):663-670. PubMed ID: 21160462
[TBL] [Abstract][Full Text] [Related]
18. Fabry disease: renal biopsy-proven cases from China.
Zhang SH; Liu ZH; Zeng CH; Li SJ; Chen HP; Su J; Li LS
J Nephrol; 2007; 20(6):716-26. PubMed ID: 18046674
[TBL] [Abstract][Full Text] [Related]
19. Fabry disease.
Tarabuso AL
Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease.
Skrunes R; Tøndel C; Leh S; Larsen KK; Houge G; Davidsen ES; Hollak C; van Kuilenburg ABP; Vaz FM; Svarstad E
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1470-1479. PubMed ID: 28625968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]